On April 26, 2025, KOFA Bio successfully held the "Hardcore Reconstruction: Fusion" Partner IVD Innovation Summit. More than 200 partners from all over the country gathered together to fully and multi-dimensionally demonstrate Kefang Bio's hardcore technical strength and perfect industrial ecological layout through a variety of agendas such as technical seminars, strategic signings, industry visits and roundtable forums. Let's review the wonderful moments of this summit together.
Looking far ahead, creating a new chapter of development
Chairman Qiu He of KOFA Biotech delivered a speech entitled "Carrying on the Past and Opening the Future, Getting Ready to Go", systematically expounding on the company's development blueprint. He mentioned that in the 21 years since returning to Hubei, Kefang has deeply witnessed and participated in the major transformation of the domestic IVD industry from dependence on imports to independent innovation. The company started as a grassroots startup, and with unremitting efforts to overcome the closed-loop problems of the entire industry chain, it has successfully built core technology platforms such as chemiluminescence, biochemical testing, fluorescence testing, and bio-immune assembly lines. The luminescence equipment and bio-immune assembly lines launched are in a leading position in the industry. In the face of many challenges such as the current centralized procurement price reduction and industry homogeneity competition, six major development goals have been proposed. In the future, Kefang Biotech will rely on its deep technical accumulation, adhere to the development concept of openness and collaboration, and work with partners to jointly open up a new ecology in the IVD industry and stride forward towards a broader development space.
Deep insights and development wisdom
Dr. Li, Dean of Kefang Strategic Development Research Institute, emphasized in his speech "Strategic Navigation, Hard-core Symbiosis" that Kefang Bio will use technological innovation as a driving force to break the development dilemma of the industry. Relying on hard-core technology platforms such as biochemical immunology assembly lines and chemiluminescence, it accelerates the process of domestic substitution, and advocates deepening the "technology + channel" ecological synergy to create industrial fusion value. Director Fu of the Infrastructure Office reviewed the thousand-day construction process of the headquarters building through "Salute to the Strugglers" and revealed the team's practical experience in overcoming difficulties in challenges such as epidemics and high temperatures. The two sharing sessions presented Kefang Bio's dual-engine development model of "hard-core technology + fighting spirit" from the dimensions of strategic top-level design and grassroots practice, highlighting the company's mission to drive the upgrading of the medical industry with innovation.
Exchange of ideas and explore the future of the industry
The roundtable session of the "Hard Core, Reconstruction, Fusion" IVD Development Forum brought together policy experts, clinical practitioners, channel dealers and business leaders to engage in in-depth dialogue around industry breakthroughs and ecological collaboration.
Policy guidance, hard-core breakthrough
Under the multiple pressures of medical insurance cost control, centralized purchasing policies and global competition, experts at the meeting discussed the path to breakthrough for domestic IVD. Policy experts suggested strengthening support for local technology research; the laboratory department called for balancing cost and quality and giving priority to domestic cost-effective equipment; distributor Mr. Zhou pointed out from the perspective of an import agent that domestic products need to build technological barriers and stable supply chains; Chairman Qiu He of KOFA Biopharma shared Kefang Biopharma's successful breakthrough experience of "full industrial chain closed loop + precise research and development", and demonstrated the practical path of achieving breakthroughs in product performance and cost advantages through independent innovation.
Ecological synergy, fusion symbiosis
Faced with the dual challenges of stricter industry regulation and continued price decline, the experts at the meeting advocated the establishment of an industrial chain coordination mechanism. Mr. Zhou emphasized that establishing a trust system and a rapid response network is the key to accelerating the localization process; Chairman Qiu He demonstrated how the "technology empowerment + channel symbiosis" model can help distributors grow and develop through the practical case of KOFA Bio. All parties agree that only when the government, medical, enterprises and business closely cooperate to build a complete "R&D-production-service" ecological closed loop can we achieve cost reduction and efficiency improvement, so that patients can benefit from it and achieve a win-win situation.
Message to the future, open a new chapter together
At the end of the forum, the guests looked forward to the future of IVD, with policies laying the foundation, clinical needs driving innovation, ecological synergy releasing energy, and technological fusion setting the tone for development. KOFA Bio will work hand in hand with its partners to build a new ecology for high-quality development of the IVD industry with an open attitude.
